Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression

NCT00771134 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

105

Enrollment

INDUSTRY

Sponsor class

Stopped Study was previously suspended and is now terminated

Conditions

Bipolar Disorder

Interventions

DRUG: Lu AA39959
DRUG: Placebo
DRUG: Quetiapine

Sponsor

H. Lundbeck A/S